E-LIB Suche - Ergebnisse für: Pau, Alice K.

1

Ex vivo sensitivity to broadly neutralizing antibodies and ..:

Rai, M. Ali ; Blazkova, Jana ; Justement, Jesse S....
eBioMedicine. 104 (2024) - p. 105151 , 2024

2

Lessons From COVID-19 for Pandemic Preparedness: Proceeding..:

Narayanasamy, Shanti ; Curtis, Lesley H ; Hernandez, Adrian F...
Clinical Infectious Diseases. 77 (2023) 12 - p. 1635-1643 , 2023

Link: https://doi.org/10.1093/..

3

Dramatic Improvement of MRI Abnormalities of HIV Dementia a..:

Dietrich, Devon K. ; Laidlaw, Elizabeth ; Hammoud, Dima A...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

4

Utilization of Direct Oral Anticoagulants in People Living ..:

George, Jomy M ; Kuriakose, Safia S ; Monroe, Anne...
Clinical Infectious Diseases. 71 (2020) 10 - p. e604-e613 , 2020

Link: https://doi.org/10.1093/..

5

Treatment of Drug-Sensitive Tuberculosis in Persons with HI:

, In: HIV and Tuberculosis,

Pau, Alice K. ; Kuriakose, Safia ; Dooley, Kelly E.. - p. 181-202 , 2019

Link: https://doi.org/10.1007/..

6

Eight-day Inpatient Directly Observed Therapy for Antiretro..:

Pau, Alice K ; Lane, H Clifford ; Proschan, Michael...
Clinical Infectious Diseases. 70 (2019) 6 - p. 1222-1225 , 2019

Link: https://doi.org/10.1093/..

7

Co-treatment of Tuberculosis and HIV: Pharmacologic Conside..:

, In: HIV and Tuberculosis,

Weld, Ethel D. ; Pau, Alice K. ; Maartens, Gary. - p. 239-267 , 2019

Link: https://doi.org/10.1007/..

8

Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug..:

Brooks, Kristina M ; George, Jomy M ; Pau, Alice K...
Clinical Infectious Diseases. 67 (2018) 2 - p. 193-201 , 2018

Link: https://doi.org/10.1093/..

9

Rapid Development of High-Level Resistance to Dolutegravir ..:

George, Jomy M ; Kuriakose, Safia S ; Dee, Nicola...
Open Forum Infectious Diseases. 5 (2018) 10 - p. , 2018

Link: https://doi.org/10.1093/..

10

Decreased Absorption of Dolutegravir and Tenofovir Disoprox..:

Brooks, Kristina M. ; Garrett, Katy L. ; Kuriakose, Safia S....
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 37 (2017) 8 - p. , 2017

Link: https://doi.org/10.1002/..

11

Efavirenz but Not Atazanavir/Ritonavir Significantly Reduce..:

Calderón, Mónica M. ; Penzak, Scott R. ; Pau, Alice K....
Clinical Infectious Diseases. 62 (2016) 8 - p. 1036-1042 , 2016

Link: https://doi.org/10.1093/..

12

The pharmacist: An indispensable partner in HIV care:

Pau, Alice K. ; Clifford Lane, H. ; Masur, Henry
American Journal of Health-System Pharmacy. 73 (2016) 7 - p. 431-431 , 2016

Link: https://doi.org/10.2146/..

13

Efavirenz but Not Atazanavir/Ritonavir Significantly Reduce..:

Calderón, Mónica M. ; Penzak, Scott R. ; Pau, Alice K....
Clinical Infectious Diseases. 62 (2016) 8 - p. 1036-1042 , 2016

Link: https://www.jstor.org/st..

14

Prevention and Treatment of Opportunistic Infections in HIV..:

Masur, Henry ; Brooks, John T. ; Benson, Constance A....
Clinical Infectious Diseases. 58 (2014) 9 - p. 1308-1311 , 2014

Link: https://www.jstor.org/st..

15

Impaired Maraviroc and Raltegravir Clearance in a Human Imm..:

Pau, Alice K. ; Penzak, Scott R. ; Boyd, Sarita D...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 32 (2012) 1 - p. , 2012

Link: https://doi.org/10.1002/..